Nebivolol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Amerigen Pharmaceuticals Inc.. The primary component is Nebivolol Hydrochloride.
| Product ID | 43975-248_02a8038f-f4bf-4f60-9888-b1233fa947d2 |
| NDC | 43975-248 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nebivolol |
| Generic Name | Nebivolol |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-04-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203659 |
| Labeler Name | Amerigen Pharmaceuticals Inc. |
| Substance Name | NEBIVOLOL HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/1 |
| Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2015-04-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA203659 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-04-28 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA203659 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-04-28 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| NEBIVOLOL HYDROCHLORIDE | 2.5 mg/1 |
| SPL SET ID: | 8f98d499-f68f-4148-8ec3-8c66ef184a83 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0904-7189 | nebivolol | nebivolol |
| 0904-7190 | nebivolol | nebivolol |
| 0904-7225 | nebivolol | nebivolol |
| 0904-7226 | nebivolol | nebivolol |
| 13668-353 | nebivolol | nebivolol |
| 13668-354 | nebivolol | nebivolol |
| 13668-355 | nebivolol | nebivolol |
| 13668-356 | nebivolol | nebivolol |
| 43975-248 | Nebivolol | Nebivolol |
| 43975-250 | Nebivolol | Nebivolol |
| 43975-249 | Nebivolol | Nebivolol |
| 43975-251 | Nebivolol | Nebivolol |